230 related articles for article (PubMed ID: 32359129)
21. Germline Genetic Features of Young Individuals With Colorectal Cancer.
Stoffel EM; Koeppe E; Everett J; Ulintz P; Kiel M; Osborne J; Williams L; Hanson K; Gruber SB; Rozek LS
Gastroenterology; 2018 Mar; 154(4):897-905.e1. PubMed ID: 29146522
[TBL] [Abstract][Full Text] [Related]
22. Spectrum of Pathogenic Germline Mutations in Chinese Lung Cancer Patients through Next-Generation Sequencing.
Tian P; Cheng X; Zhao Z; Zhang Y; Bao C; Wang Y; Cai S; Ma G; Huang Y
Pathol Oncol Res; 2020 Jan; 26(1):109-114. PubMed ID: 31721094
[TBL] [Abstract][Full Text] [Related]
23. Germline mutations of renal cancer predisposition genes and clinical relevance in Chinese patients with sporadic, early-onset disease.
Wu J; Wang H; Ricketts CJ; Yang Y; Merino MJ; Zhang H; Shi G; Gan H; Linehan WM; Zhu Y; Ye D
Cancer; 2019 Apr; 125(7):1060-1069. PubMed ID: 30548481
[TBL] [Abstract][Full Text] [Related]
24. Enrichment of cancer-predisposing germline variants in adult and pediatric patients with acute lymphoblastic leukemia.
Douglas SPM; Lahtinen AK; Koski JR; Leimi L; Keränen MAI; Koskenvuo M; Heckman CA; Jahnukainen K; Pitkänen E; Wartiovaara-Kautto U; Kilpivaara O
Sci Rep; 2022 Jun; 12(1):10670. PubMed ID: 35739278
[TBL] [Abstract][Full Text] [Related]
25. Clinical profile and mutation spectrum of long QT syndrome in Saudi Arabia: The impact of consanguinity.
Al-Hassnan ZN; Al-Fayyadh M; Al-Ghamdi B; Shafquat A; Mallawi Y; Al-Hadeq F; Tulbah S; Shinwari ZMA; Almesned A; Alakhfash A; Al Fadly F; Hersi AS; Alhayani A; Al-Hashem A; Arafah D; Dzimiri N; Meyer B; Rababh M; Al-Manea W
Heart Rhythm; 2017 Aug; 14(8):1191-1199. PubMed ID: 28438721
[TBL] [Abstract][Full Text] [Related]
26. Frequency of pathogenic germline variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in ductal carcinoma in situ diagnosed in women under the age of 50 years.
Petridis C; Arora I; Shah V; Megalios A; Moss C; Mera A; Clifford A; Gillett C; Pinder SE; Tomlinson I; Roylance R; Simpson MA; Sawyer EJ
Breast Cancer Res; 2019 May; 21(1):58. PubMed ID: 31060593
[TBL] [Abstract][Full Text] [Related]
27. Estimated number of adult survivors of childhood cancer in United States with cancer-predisposing germline variants.
Wilson CL; Wang Z; Liu Q; Ehrhardt MJ; Mostafavi R; Easton J; Mulder H; Hedges DJ; Wang S; Rusch M; Edmonson M; Levy S; Lanctot JQ; Currie K; Lear M; Patel A; Sapkota Y; Brooke RJ; Moon W; Chang TC; Chen W; Kesserwan CA; Wu G; Nichols KE; Hudson MM; Zhang J; Robison LL; Yasui Y
Pediatr Blood Cancer; 2020 Feb; 67(2):e28047. PubMed ID: 31736278
[TBL] [Abstract][Full Text] [Related]
28. The spectrum of genetic variants in hereditary pancreatic cancer includes Fanconi anemia genes.
Slavin TP; Neuhausen SL; Nehoray B; Niell-Swiller M; Solomon I; Rybak C; Blazer K; Adamson A; Yang K; Sand S; Guerrero-Llamas N; Castillo D; Herzog J; Wu X; Tao S; Raja S; Chung V; Singh G; Nadesan S; Brown S; Cruz-Correa M; Petersen GM; Weitzel J;
Fam Cancer; 2018 Apr; 17(2):235-245. PubMed ID: 28687971
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of genetic susceptibility for breast and ovarian cancer in a non-cancer related study population: secondary germline findings from a Swiss single centre cohort.
Kraemer D; Azzarello-Burri S; Steindl K; Boonsawat P; Zweier M; Dedes KJ; Joset P; Fink D; Rauch A
Swiss Med Wkly; 2019 Aug; 149():w20092. PubMed ID: 31422574
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of pathogenetic mutations in breast cancer predisposition genes in population-based studies conducted among Chinese women.
Zeng C; Guo X; Wen W; Shi J; Long J; Cai Q; Shu XO; Xiang Y; Zheng W
Breast Cancer Res Treat; 2020 Jun; 181(2):465-473. PubMed ID: 32318955
[TBL] [Abstract][Full Text] [Related]
31. Identification of a novel TP53 cancer susceptibility mutation through whole-genome sequencing of a patient with therapy-related AML.
Link DC; Schuettpelz LG; Shen D; Wang J; Walter MJ; Kulkarni S; Payton JE; Ivanovich J; Goodfellow PJ; Le Beau M; Koboldt DC; Dooling DJ; Fulton RS; Bender RH; Fulton LL; Delehaunty KD; Fronick CC; Appelbaum EL; Schmidt H; Abbott R; O'Laughlin M; Chen K; McLellan MD; Varghese N; Nagarajan R; Heath S; Graubert TA; Ding L; Ley TJ; Zambetti GP; Wilson RK; Mardis ER
JAMA; 2011 Apr; 305(15):1568-76. PubMed ID: 21505135
[TBL] [Abstract][Full Text] [Related]
32. Identification of pathogenic germline variants in a large Chinese lung cancer cohort by clinical sequencing.
Yu Z; Zhang Z; Liu J; Wu X; Fan X; Pang J; Bao H; Yin J; Wu X; Shao Y; Liu Z; Liu F
Mol Oncol; 2024 May; 18(5):1301-1315. PubMed ID: 37885353
[TBL] [Abstract][Full Text] [Related]
33. Whole Exome Sequencing Identifies Novel Genetic Alterations in Patients with Pheochromocytoma/Paraganglioma.
Seo SH; Kim JH; Kim MJ; Cho SI; Kim SJ; Kang H; Shin CS; Park SS; Lee KE; Seong MW
Endocrinol Metab (Seoul); 2020 Dec; 35(4):909-917. PubMed ID: 33397043
[TBL] [Abstract][Full Text] [Related]
34. Whole-exome sequencing of a rare case of familial childhood acute lymphoblastic leukemia reveals putative predisposing mutations in Fanconi anemia genes.
Spinella JF; Healy J; Saillour V; Richer C; Cassart P; Ouimet M; Sinnett D
BMC Cancer; 2015 Jul; 15():539. PubMed ID: 26201965
[TBL] [Abstract][Full Text] [Related]
35. Genetic drivers of Cushing's disease: Frequency and associated phenotypes.
Hernández-Ramírez LC; Pankratz N; Lane J; Faucz FR; Chittiboina P; Kay DM; Beethem Z; Mills JL; Stratakis CA
Genet Med; 2022 Dec; 24(12):2516-2525. PubMed ID: 36149413
[TBL] [Abstract][Full Text] [Related]
36. Investigation of clinically relevant germline variants detected by next-generation sequencing in patients with childhood cancer: a review of the literature.
Sylvester DE; Chen Y; Jamieson RV; Dalla-Pozza L; Byrne JA
J Med Genet; 2018 Dec; 55(12):785-793. PubMed ID: 30287599
[TBL] [Abstract][Full Text] [Related]
37. Exome Sequencing-Based Screening for BRCA1/2 Expected Pathogenic Variants Among Adult Biobank Participants.
Manickam K; Buchanan AH; Schwartz MLB; Hallquist MLG; Williams JL; Rahm AK; Rocha H; Savatt JM; Evans AE; Butry LM; Lazzeri AL; Lindbuchler DM; Flansburg CN; Leeming R; Vogel VG; Lebo MS; Mason-Suares HM; Hoskinson DC; Abul-Husn NS; Dewey FE; Overton JD; Reid JG; Baras A; Willard HF; McCormick CZ; Krishnamurthy SB; Hartzel DN; Kost KA; Lavage DR; Sturm AC; Frisbie LR; Person TN; Metpally RP; Giovanni MA; Lowry LE; Leader JB; Ritchie MD; Carey DJ; Justice AE; Kirchner HL; Faucett WA; Williams MS; Ledbetter DH; Murray MF
JAMA Netw Open; 2018 Sep; 1(5):e182140. PubMed ID: 30646163
[TBL] [Abstract][Full Text] [Related]
38. Novel candidates of pathogenic variants of the BRCA1 and BRCA2 genes from a dataset of 3,552 Japanese whole genomes (3.5KJPNv2).
Tokunaga H; Iida K; Hozawa A; Ogishima S; Watanabe Y; Shigeta S; Shimada M; Yamaguchi-Kabata Y; Tadaka S; Katsuoka F; Ito S; Kumada K; Hamanaka Y; Fuse N; Kinoshita K; Yamamoto M; Yaegashi N; Yasuda J
PLoS One; 2021; 16(1):e0236907. PubMed ID: 33428613
[TBL] [Abstract][Full Text] [Related]
39. [Application of next-generation sequencing in detection of BRCA1/2 and homologous recombination repair pathway multi-genes germline mutation and correlation analysis].
Chen YL; Zhuo ZL; Liu C; Xie F; Yang ZY; Liu PF; Wang S; Zhao XT
Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Mar; 56(3):302-311. PubMed ID: 35381651
[No Abstract] [Full Text] [Related]
40. Prevalence of Germline Alterations on Targeted Tumor-Normal Sequencing of Esophagogastric Cancer.
Ku GY; Kemel Y; Maron SB; Chou JF; Ravichandran V; Shameer Z; Maio A; Won ES; Kelsen DP; Ilson DH; Capanu M; Strong VE; Molena D; Sihag S; Jones DR; Coit DG; Tuvy Y; Cowie K; Solit DB; Schultz N; Hechtman JF; Offit K; Joseph V; Mandelker D; Janjigian YY; Stadler ZK
JAMA Netw Open; 2021 Jul; 4(7):e2114753. PubMed ID: 34251444
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]